APA (7th ed.) Citation

Zou, Z., Wu, L., Hao, X., Li, Y., Liang, L., Gu, Y., . . . Xing, P. Impact of EML4‐ALK Variants and TP53 Status on the Efficacy of ALK Inhibitors in Patients With Non‐small Cell Lung Cancer. Wiley.

Chicago Style (17th ed.) Citation

Zou, Zihua, Lige Wu, Xuezhi Hao, Yan Li, Li Liang, Yangchun Gu, Jianming Ying, Junling Li, and Puyuan Xing. Impact of EML4‐ALK Variants and TP53 Status on the Efficacy of ALK Inhibitors in Patients With Non‐small Cell Lung Cancer. Wiley.

MLA (9th ed.) Citation

Zou, Zihua, et al. Impact of EML4‐ALK Variants and TP53 Status on the Efficacy of ALK Inhibitors in Patients With Non‐small Cell Lung Cancer. Wiley.